Pfizer seals up to $7.3bn takeover of weight loss drugmaker Metsera
PositiveFinancial Markets

Pfizer has made a significant move by acquiring Metsera for up to $7.3 billion, marking the largest takeover by a major pharmaceutical company in the weight loss sector. This deal is crucial as it positions Pfizer in a rapidly expanding market, highlighting the growing demand for effective weight loss solutions. With obesity rates on the rise, this acquisition not only strengthens Pfizer's portfolio but also reflects the company's commitment to addressing public health challenges.
— Curated by the World Pulse Now AI Editorial System